Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34+ cells in a rabbit model of myocardial infarction
- 508 Downloads
The objective of the study is to investigate the effect of hypoxic preconditioning on the immunomodulatory properties of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) and the effect of cotransplantation of hUC-MSCs and human umbilical cord blood (hUCB)-derived CD34+ cells in a rabbit model of myocardial infarction. hUC-MSCs with or without hypoxic preconditioning by cobalt chloride were plated in a 24-well plate, and then cocultured with hUCB-CD34+ cells and PBMCs for 96 h at 37 °C in a 5 % CO2 incubator. For the negative control, hUC-MSCs were omitted. The groups were divided as follows: A1 = HP-MSCs + hUCB-CD34+ cells + PBMC, A2 = hUC-MSCs + hUCB-CD34+ cells + PBMC, Negative Control = hUCB-CD34+ cells + PBMC. Culture supernatants of each group were collected, and the IL-10 and IFN-γ levels were measured by ELISA. A rabbit model of MI was established using a modified Fujita method. The animals were then randomized into three groups and received intramyocardial injections of 0.4 ml of PBS alone (n = 8, PBS group), hUC-MSCs in PBS (n = 8, hUC-MSCs group), or hUC-MSCs + CD34+ cells in PBS (n = 8, Cotrans group), at four points in the infarct border zone. Echocardiography was performed at baseline, 4 weeks after MI induction, and 4 weeks after cell transplantation, respectively. Stem cell differentiation and neovascularization in the infracted area were characterized for the presence of cardiac Troponin I (cTnI) and CD31 by immunohistochemical staining, and the extent of myocardial fibrosis was evaluated by hematoxylin and eosin (H&E) and Masson’s trichrome. IFN-γ was 27.00 ± 1.11, 14.20 ± 0.81, and 7.22 ± 0.14 pg/ml, and IL-10 was 31.68 ± 3.08, 61.42 ± 1.08, and 85.85 ± 1.80 pg/ml for the Control, A1 and A2 groups, respectively, which indicated that hUCB-CD34+ cells induced immune reaction of peripheral blood mononuclear cells, whereas both hUC-MSCs and HP-MSCs showed an immunosuppressive effect, which, however, was attenuated by hypoxic preconditioning. The Cotrans group had less collagen deposition in the infarcted myocardium and better heart function than the hUC-MSCs or PBS group. The presence of cTnI-positive cells and CD31-positive tubular structures indicated the differentiation of stem cells into cardiomyocytes and neovascularization. The microvessel density was 12.19 ± 3.05/HP for the hUC-MSCs group and 31.63 ± 2.45/HP for the Cotrans group, respectively (P < 0.01). As a conclusion, both hUC-MSCs and HP-MSCs have an immunosuppressive effect on lymphocytes, which, however, can be attenuated by hypoxic preconditioning. Cotransplantation of hUC-MSCs and hUCB-CD34+ cells can improve heart function and decrease collagen deposition in post-MI rabbits. Thus, a combined regimen of hUC-MSCs and hUCB-CD34+ cells would be more desirable than either cells administered alone. This is most likely due to the increase of cardiomyocytes and enhanced angiogenesis in the infarcted myocardium.
KeywordsMyocardial Infarction Umbilical cord mesenchymal stem cells Umbilical cord blood-derived CD34+ Cells Cotransplantation
This study was supported by the Natural Science funds of Tianjin Province (10JCYBJC14000). The authors are very grateful for the sincere help and excellent technical support by the Key Laboratory of Artificial Cell, Institute of Hepatobiliary Disease of Tianjin Third Central Hospital.
Conflict of interest
The authors declare that no conflicts of interest exist.
- 1.Yang Jinfu, Zhou Wenwu, Zheng Wei, Ma Yanlin, Lin Ling, Tang Tao, Liu Jianxin, Jiefeng Yu, Zhou Xinmin, Jianguo Hu (2007) Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107:17–29. doi: 10.1159/000093609 PubMedCrossRefGoogle Scholar
- 2.Mathieu Eva, Lamirault Guillaume, Toquet Claire, Lhommet Pierre, Rederstorff Emilie, Sourice Sophie, Biteau Kevin, Hulin Philippe, Forest Virginie, Weiss Pierre, Guicheux Jérôme, Lemarchand Patricia (2012) Intramyocardial delivery of mesenchymal stem cell-seeded hydrogel preserves cardiac function and attenuates ventricular remodeling after myocardial infarction. PLoS One 7(12):e51991. doi: 10.1371/journal.pone.0051991 PubMedCentralPubMedCrossRefGoogle Scholar
- 3.Zhang J, Chen G-H, Wang Y-W, Zhao J, Duan H-F, Liao L-M, Zhang X-Z, Chen Y-D, Hu C (2012) Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton’s Jelly mesenchymal stem cells after myocardial infarction. Chin Med J 125(19):3472–3478. doi: 10.3760/cma.j.issn.0366-6999.2012.19.020 PubMedGoogle Scholar
- 4.Latifpour M, Nematollahi-Mahani SN, Deilamy M, Azimzadeh BS, Eftekhar- Vaghefi SH, Nabipour F, Najafipour H, Nakhaee N, Yaghoubi M, Eftekhar-Vaghefi R, Salehinejad P, Azizi H (2011) Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells. Cardiology 120(1):9–18. doi: 10.1159/000332581 PubMedGoogle Scholar
- 5.Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET (2010) Human CD34 cells in experimental myocardial infarction long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106:1904–1911. doi: 10.1161/CIRCRESAHA.110.221762 PubMedCentralPubMedCrossRefGoogle Scholar
- 6.Hu CH, Li ZM, Du ZM, Zhang AX, Rana JS, Liu DH, Yang DY, Wu GF (2010) Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction. Clin Exp Pharmacol Physiol 37(5–6):551–556. doi: 10.1111/j.1440-1681.2010.05347.x PubMedCrossRefGoogle Scholar
- 11.Barclay GR, Tura O, Samuel K, Hadoke PW, Mills NL, Newby DE, Turner ML (2012) Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization. Stem Cell Res Ther 3(4):23. doi: 10.1186/scrt114 PubMedCentralPubMedCrossRefGoogle Scholar
- 12.Xinyang Hu, Shan Ping Yu, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L (2008) Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and Angiogenesis. J Thorac Cardiovasc Surg 135(4):799–808. doi: 10.1016/j.jtcvs.2007.07.071 CrossRefGoogle Scholar
- 18.Schneider C, Jaquet K, Geidel S, Rau T, Malisius R, Boczor S, Zienkiewicz T, Kuck KH, Krause K (2009) Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: strain rate imaging in a model of hibernating myocardium. J Am Soc Echocardiogr 22(10):1180–1189. doi: 10.1016/j.echo.2009.06.011 PubMedCrossRefGoogle Scholar
- 19.Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E (2013) Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse. EMBO Mol Med 5(2):191–209. doi: 10.1002/emmm.201201737 PubMedCentralPubMedCrossRefGoogle Scholar
- 20.Takeda Y, Mori T, Imabayashi H, Kiyono T, Gojo S, Miyoshi S, Hida N, Ita M, Segawa K, Ogawa S, Sakamoto M, Nakamura S, Umezawa A (2004) Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? J Gene Med 6(8):833–845. doi: 10.1002/jgm.583 PubMedCrossRefGoogle Scholar
- 21.Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127(2):213–223. doi: 10.1161/CIRCULATIONAHA.112.131110 PubMedCentralPubMedCrossRefGoogle Scholar
- 24.Iso Y, Spees JL, Serrano C, Bakondi B, Pochampally R, Song YH, Sobel BE, Delafontaine P, Prockop DJ (2007) Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354(3):700–706. doi: 10.1016/j.bbrc.2007.01.045 PubMedCentralPubMedCrossRefGoogle Scholar
- 25.Sato T, Iso Y, Uyama T, Kawachi K, Wakabayashi K, Omori Y, Soda T, Shoji M, Koba S, Yokoyama S, Fukuda N, Saito S, Katagiri T, Kobayashi Y, Takeyama Y, Umezawa A, Suzuki H (2011) Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest 91(4):553–564. doi: 10.1038/labinvest.2010.202 PubMedCrossRefGoogle Scholar
- 27.Cheng H, Qiu L, Ma J, Zhang H, Cheng M, Li W, Zhao X, Liu K (2011) Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Mol Biol Rep 38(8):5161–5168. doi: 10.1007/s11033-010-0665-2 PubMedCrossRefGoogle Scholar
- 28.Chen X, Zhang F, He X, Xu Y, Yang Z, Chen L, Zhou S, Yang Y, Zhou Z, Sheng W, Zeng Y (2013) Chondrogenic differentiation of umbilical cord-derived mesenchymal stem cells in type I collagen-hydrogel for cartilage engineering. Injury 44(4):540–549. doi: 10.1016/j.injury.2012.09.024 PubMedCrossRefGoogle Scholar
- 29.Lu L-L, Liu Y-J, Yang S-G, Zhao Q-J, Wang X, Gong W, Han Z-B, Zhen-Shu X, Lu Y-X, Liu D, Chen Z-Z, Han Z-C (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91(8):1017–1026PubMedGoogle Scholar